|
Statement from Dey, L.P. Regarding Pricing Litigation by the U.S. Department of Justice.
Publication: PR Newswire Publication Date: 11-SEP-06 |
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2006 PR Newswire Association LLC
NAPA, Calif., Sept. 11 /PRNewswire/ -- Dey, L.P. unequivocally denies any wrongdoing in the pricing or marketing of its generic or branded pharmaceutical products. In response to claims filed by the Department of Justice (DOJ), DEY maintains that it has consistently participated legally and ethically within national and state reimbursement systems. DEY intends to defend itself vigorously against the DOJ's claims.
"When virtually an entire industry...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from PR Newswire |
BMB Munai, Inc. Announces Cessation of Re-entry Operations on Borly-2 ...
September 11, 2006
|
Avis Is Recognized for 'Trying Harder' to Support Travelers With Disab...
September 11, 2006
|
Sensicore Introduces First Responder Kit to Aid in Troubleshooting and...
September 11, 2006
|
County of Los Angeles Office of Emergency Management Recognizes Charle...
September 11, 2006
|
ITT Educational Services, Inc. to Make Investor Presentation.
September 11, 2006
|
|
| Find companies classified under Pharmaceutical preparations |
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
